Abbott Laboratories Com Stk NPV (NYSE:ABT)

Only company that constantly gets new patents by modifying the formula..to prevent generic drug makers like TEVA to manufacture them.

Result: you have to pay premium as there's no generic version available for most of its drugs.

80 years of consistent dividends; long-term growth stock.

dividends + boomers + stability

Better to get an great company at an ok price...would like to buy on a dip...but sound company...

Even though I would rather see a company reinvest dividends because if I am investing in them I have to believe they can make more money with the dividend than I can. Having said that, Abbot has had increasing dividends for over 10 years. This shows strength in the midst of one recession and Depression 2. Important factors for me are that: (1) ABT can pay off its' long term debt with only two years of net income; (2) its' current liabilities are half of its' current assets; (3) its' amount of shares outstanding has remained constant for the past 10 years meaning that it doesn't use stock offerings to raise money; (4) for a company that has to continue to reinvent it's product line every few years it's R&D is half less than half of its' net income, and finally its' PE is about 15 which is at an all time low over the past 10 years. For a value investor, at this time the stock is undervalued at 78% based on earing 20% over the next ten years based on its' past 10 years of shareholder's equity. Nice :)

FEW PATENTS SET TO EXPIRE

Good Ratios

Drug and Dividends what more can you ask for

Tracking some of my real portfolio

Solid company - health care has under performed S&P 500 - improving earnings

well run company with a relatively safe dividend

Abbott has been in a large growth slow movement pattern for a significant timeframe. after earning, expect ABT to break resistance for a 4 to 5 % tick up.

Obamacare is scary but infections are getting worse. Abbott is the best antimicrobial maker period.

Good strong company that is diversified well, the four segments of this company seem to be very promising. Let's just hope Obama care doesn't make this company tank

Good vaue stock and yield. Like chart.

100

Hugely stable and mature, I believe this low-beta slow-grower is undervalued relative to the pricey market.

Earnings just keep growing!

Rock steady, dividend history, reasonably well managed, well-diversified in terms of product, markets and geographies. Plus, it's PE of 12.93, EPS (ttm) of 3.43, and Div & Yield of 1.60 (3.60%) is not easiy matched. Hello???